Engineers Gate Manager’s Terns Pharmaceuticals TERN Stock Holding History

Engineers Gate Manager’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,880	Closed	-$521K	–	2612
2026 Q1	$521K	Sell	9,880 -6,885	-41%	-$283K	0.01%	1395
2025 Q4	$677K	Buy	+16,765	New	+$387K	0.01%	1220
2025 Q3	–	Sell	-11,056	Closed	-$41.2K	–	2524
2025 Q2	$41.2K	Buy	+11,056	New	+$34.5K	﹤0.01%	2061
2025 Q1	–	Sell	-64,666	Closed	-$358K	–	2577
2024 Q4	$358K	Buy	64,666 +32,298	+100%	+$219K	0.01%	1630
2024 Q3	$270K	Sell	32,368 -7,172	-18%	-$59K	0.01%	1666
2024 Q2	$269K	Buy	39,540 +22,274	+129%	+$135K	0.01%	1519
2024 Q1	$113K	Buy	+17,266	New	+$113K	﹤0.01%	1730

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Engineers Gate Manager's TERN Position: Q2 2026 in Review

Engineers Gate Manager sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 9,880 shares — an estimated $521K sold.

Engineers Gate Manager first reported a position in TERN in Q1 2024 and held it in 7 quarters. The position peaked at $677K in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Engineers Gate Manager reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 9,880 Terns Pharmaceuticals shares in Q2 2026, an estimated $521K.
Engineers Gate Manager first reported a position in Terns Pharmaceuticals in Q1 2024 and held it in 7 quarters.
Engineers Gate Manager's Terns Pharmaceuticals position peaked at $677K in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.